Literature DB >> 30457095

Case Report: Central Nervous System Strongyloidiasis: Two Cases Diagnosed Antemortem.

Jennifer Tam1, Kevin L Schwartz2,3, Jay Keystone4, Dimitri Dimitrakoudis5, Mark Downing2, Sigmund Krajden2.   

Abstract

Central nervous system (CNS) strongyloidiasis is a known but rare form of disseminated infection. The diagnosis is often made postmortem, with only five published cases of an antemortem diagnosis. We report two fatal cases of CNS strongyloidiasis diagnosed antemortem, with Strongyloides stercoralis larvae visualized in the CNS sample in one case. Risk factors for disseminated strongyloidiasis common to both cases included origination from the Caribbean, underlying human T-lymphotropic virus-1 infection, and recent prednisone use. Both cases occurred in Canada, where the occurrence of Strongyloides is uncommon, and serve as a reminder to maintain a high index of suspicion in patients with epidemiologic or clinical risk factors for dissemination.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30457095      PMCID: PMC6335887          DOI: 10.4269/ajtmh.18-0813

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  12 in total

1.  Fatal strongyloidiasis in immunosuppressed patients.

Authors:  D T Purtilo; W M Meyers; D H Connor
Journal:  Am J Med       Date:  1974-04       Impact factor: 4.965

2.  Disseminated strongyloidiasis with cerebral involvement. A complication of corticosteroid therapy.

Authors:  L I Neefe; O Pinilla; V F Garagusi; H Bauer
Journal:  Am J Med       Date:  1973-12       Impact factor: 4.965

3.  Disseminated Strongyloides stercoralis in an immunosuppressed host.

Authors:  S L Bradley; D E Dines; N S Brewer
Journal:  Mayo Clin Proc       Date:  1978-05       Impact factor: 7.616

4.  Disseminated strongyloidiasis with central nervous system involvement diagnosed antemortem in a patient with acquired immunodeficiency syndrome and Burkitts lymphoma.

Authors:  J P Dutcher; S L Marcus; H B Tanowitz; M Wittner; J Z Fuks; P H Wiernik
Journal:  Cancer       Date:  1990-12-01       Impact factor: 6.860

Review 5.  Complicated and fatal Strongyloides infection in Canadians: risk factors, diagnosis and management.

Authors:  Sue Lim; Kevin Katz; Sigmund Krajden; Milan Fuksa; Jay S Keystone; Kevin C Kain
Journal:  CMAJ       Date:  2004-08-31       Impact factor: 8.262

6.  Worms on the brain: fatal meningoencephalitis from disseminated strongyloides infection.

Authors:  Osman Dokmeci; Brittany Forshay; Stephen J Scholand
Journal:  Conn Med       Date:  2013-01

Review 7.  Strongyloides stercoralis in the Immunocompromised Population.

Authors:  Paul B Keiser; Thomas B Nutman
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

8.  Case report: Antemortem diagnosis of central nervous system strongyloidiasis.

Authors:  R S Meltzer; C Singer; D Armstrong; K Mayer; W H Knapper
Journal:  Am J Med Sci       Date:  1979 Jan-Feb       Impact factor: 2.378

9.  Strongyloides meningitis.

Authors:  A Belani; D Leptrone; J W Shands
Journal:  South Med J       Date:  1987-07       Impact factor: 0.954

10.  CATMAT statement on disseminated strongyloidiasis: Prevention, assessment and management guidelines.

Authors:  A K Boggild; M Libman; C Greenaway; A E McCarthy
Journal:  Can Commun Dis Rep       Date:  2016-01-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.